foxo4-dri senolytic mice baar 2017 induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation Molecular modelling of the FOXO4-TP53
Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Tools to eliminate senescent cells Nature The costs and benefits of senotherapeutics for human health The Lancet Healthy Longevity FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data
Pay in 4 interest-free payments of $5.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17


00300-7/asset/fc51add5-22b1-4645-9507-e89d0738c67a/main.assets/gr1_lrg.jpg)
